State Street Corp Immunity Bio, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 8,654,460 shares of IBRX stock, worth $22.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,654,460

Previous 7,864,052 10.05%

Holding current value

$22.8 Million

Previous $49.7 Million 35.4%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.32 - $6.7 $2.62 Million - $5.3 Million	790,408 Added 10.05%	8,654,460 $32.1 Million
Q2 2024 Aug 14, 2024	SELL	$4.82 - $9.15 $30.5 Million - $57.8 Million	-6,320,225 Reduced 44.56%	7,864,052 $49.7 Million
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $15.2 Million - $29.1 Million	4,713,368 Added 49.77%	14,184,277 $76.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $8.44 Million - $35.2 Million	6,751,317 Added 248.25%	9,470,909 $47.5 Million
Q3 2023 Nov 14, 2023	SELL	$1.29 - $3.1 $74,360 - $178,696	-57,644 Reduced 2.08%	2,719,592 $4.6 Million
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $194,957 - $816,781	127,423 Added 4.81%	2,777,236 $7.72 Million
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $5.52 Million - $19.5 Million	-4,086,238 Reduced 60.66%	2,649,813 $4.82 Million
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $377,231 - $587,094	86,720 Added 1.3%	6,736,051 $34.2 Million
Q3 2022 Nov 15, 2022	BUY	$3.65 - $6.43 $17.4 Million - $30.7 Million	4,780,807 Added 255.86%	6,649,331 $33 Million
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $13.1 Million - $30 Million	-4,891,782 Reduced 72.36%	1,868,524 $6.95 Million
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $2.75 Million - $4.1 Million	544,929 Added 8.77%	6,760,306 $37.9 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $5.09 Million - $9.14 Million	897,597 Added 16.88%	6,215,377 $37.8 Million
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $10.3 Million - $16 Million	1,124,160 Added 26.81%	5,317,780 $51.8 Million
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $25 Million - $41.7 Million	1,861,048 Added 79.79%	4,193,620 $59.9 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $29.9 Million - $98.6 Million	2,332,572 New	2,332,572 $55.4 Million

Others Institutions Holding IBRX

# of Institutions

204

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Immunity Bio, Inc. Transaction History